rss
J Neurol Neurosurg Psychiatry 2000;68:317-322 doi:10.1136/jnnp.68.3.317
  • Paper

Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases

  1. H Yamauchia,e,
  2. H Fukuyamab,
  3. Y Dongb,
  4. H Nabatamed,
  5. Y Nagahamaa,
  6. S Nishizawac,
  7. J Konishic,
  8. H Shioe
  1. aDepartment of Neurology, Faculty of Medicine, Kyoto University, Kyoto, Japan, bDepartment of Brain Pathophysiology, cDepartment of Radiology and Nuclear Medicine, dDepartment of Neurology, Shiga Medical Center for Adults, Moriyama, Shiga, Japan, eResearch Institute
  1. Dr Hiroshi Yamauchi, Research Institute, Shiga Medical Center, 5–4–30 Moriyama, Moriyama-city, Shiga 524–8524, Japan email yamauchi{at}shigamed.moriyama.shiga.jp
  • Received 15 March 1999
  • Revised 23 August 1999
  • Accepted 3 September 1999

Abstract

OBJECTIVES It remains controversial whether selective neuronal ischaemic change develops in patients with occlusion of the large cerebral arteries. Previous studies have shown atrophy of the corpus callosum with reduced cortical oxygen metabolism in large cerebral arterial occlusive diseases, which might be indirect evidence of loss of the neurons in cortical layer 3. Recent studies of patients with ischaemic cerebrovascular diseases have demonstrated reduced central benzodiazepine receptor (BZR) binding in the normal appearing cortical areas, which might be more direct evidence of changes of the neurons. Although pathophysiology of the decreased BZR is unclear, a decrease in the cortical BZR binding with neuronal loss would cause atrophy of the corpus callosum. The purpose of this study was to determine whether atrophy of the corpus callosum is associated with a decrease in cortical BZR binding in large cerebral arterial occlusive diseases.

METHODS Seven patients with occlusive diseases of the middle cerebral or internal carotid artery and only minor subcortical infarctions were studied. Single photon emission tomographic images of 123I labelled iomazenil (IMZ) obtained 180 minutes after injection were analysed for BZR binding. The midsagittal corpus callosum area/skull area ratio (on T1 weighted magnetic resonance images) was compared with the cerebral IMZ uptake/cerebellar IMZ uptake ratio.

RESULTS Compared with 23 age and sex matched control subjects, the patients had significantly decreased callosal area/skull area ratio. The degree of corpus callosum atrophy was significantly and strongly (ρ=0.99, p<0.02) correlated with that of the decreases in the mean cerebral cortical IMZ uptake ratio.

CONCLUSION Corpus callosum atrophy may occur in association with a decrease in cortical BZR binding in large cerebral arterial occlusive diseases. Corpus callosum atrophy with decreased cortical BZR binding might reflect cortical neuronal damage in large cerebral arterial occlusive diseases.

Footnotes

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

    BMJ Careers - Latest neurology and neurosurgery jobs